During the past decade, Columbia University - Department of Neurology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Columbia University - Department of Neurology" are "Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)" (1 trials) and "Idiopathic Hypersomnia" (1 trials). Many other conditions were trialed in "Columbia University - Department of Neurology" in a lesser frequency.

Most popular intervention types in "Columbia University - Department of Neurology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pentetrazol (PTZ)" (1 trials), "Placebo" (1 trials), "Placebo oral capsule" (1 trials) and "UX007" (1 trials). Other intervention names were less common.

The vast majority of trials in "Columbia University - Department of Neurology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Columbia University - Department of Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Columbia University - Department of Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Columbia University - Department of Neurology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".